August 23, 2024 | I Peace, Inc

News

Stem Cell Therapy developers I Peace and iCamuno Biotherapeutics Start Natural Killer Cell Trial for Ovarian Cancer

•

August 23, 2024

•

Press

I Peace strives to democratize autologous cell therapy

•

June 11, 2024

•

Other

I Peace selected as the “Top Innovator” recipient at the Venture Summit West 2024

•

April 9, 2024

•

Other

I Peace receives the “Award for Excellence” at the Well-being & Age-Tech Award 2023

•

December 8, 2023

•

Events

GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant

•

December 8, 2023

•

Press

CEO Koji Tanabe presents at the 5th World Science and Technology Development Forum in China

•

November 30, 2023

•

Events

I Peace, Inc. is shortlisted for the 2024 Advanced Therapies Awards

•

November 10, 2023

•

Other

Using GMP iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine

•

November 2, 2023

•

Press

Personal iPS cell banking service “My Peace” website launched

•

October 12, 2023

•

Other

Kyoto University Students Visit I Peace’s Head Office

•

September 19, 2023

•

Other

Reach out to us to learn more